Presentation SIRFLOX is the first, large randomised controlled multicentre international study to examine the use of chemo-radiotherapy in the first-line treatment of patients with colorectal liver metastases.
The results of the SIRFLOX study will be debated in a multidisciplinary forum together with specialty workshops discussing the implications to clinical practice.

1st Announcement Sirflox meeting Venice Web